Aptevo Therapeutics Inc.APVONASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank75
3Y CAGR-81.5%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
-81.5%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$225000.00-52.3%
2024$472000.00-95.4%
2023$10.23M-71.3%
2022$35.66M+545.2%
2021$-8.01M-133.5%
2020$-3.43M-63.1%
2019$-2.10M-3.9%
2018$-2.02M-4.1%
2017$-1.94M+84.6%
2016$-12.64M-